Weight Loss Drugs’ Messy Rise: How Ozempic, Wegovy, and Mounjaro Really Affect Patients — and What Comes Next
Obesity was formally recognized as a disease just a decade ago, in 2013. The medical designation was intended to distinguish excess weight as a complex, chronic illness, not a failing of personal willpower — though there was, and remains, some … Continue reading →